Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. 1995

T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
Genentech, Inc., South San Francisco, California 94080-4990, USA.

Hepatocyte growth factor (HGF) is a potent mitogen, motogen, and morphogen for various epithelial cell types. The pleiotropic effects of HGF are mediated by its binding to a specific high affinity receptor, c-Met. In addition, HGF binds to heparan sulfate proteoglycans on cell surfaces and within the extracellular matrix. Incubation of HGF with 0.1, 1.0, and 10 micrograms/ml of heparin, heparan sulfate, or dextran sulfate resulted in a concentration-dependent increase in mitogenic potency in a primary rat hepatocyte bioassay, whereas sodium sulfate or fucoidan did not. Although co-incubation of HGF with sulfated compounds that enhanced HGF-dependent mitogenesis did not alter the binding isotherm of HGF for the c-Met receptor in a solid phase assay, an increase in autophosphorylation of the c-Met receptor in intact A549 cells was observed upon their addition. A series of chemically sulfated malto-oligosaccharides varying in unit size and charge was tested in the bioassay in order to provide additional insights into the nature of the HGF-heparin interaction. While sulfated di-, tri-, tetra-, and pentasaccharides did not significantly potentiate HGF-dependent mitogenesis, larger oligosaccharides such as the sulfated hexa-, hepta-, or a sulfated oligosaccharide mixture containing decasaccharides resulted in an approximate 2-, 4-, and 7-fold enhancement, respectively. We observed a correlation between the sulfated oligosaccharide preparations that enhanced mitogenic potency and those that promoted HGF oligomerization in vitro, as measured by gel filtration and analytical ultracentrifugation. These findings indicate that heparin-like molecules can stabilize HGF oligomers, which may facilitate c-Met receptor dimerization and activation.

UI MeSH Term Description Entries
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013431 Sulfates Inorganic salts of sulfuric acid. Sulfate,Sulfates, Inorganic,Inorganic Sulfates

Related Publications

T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
July 1993, Molecular and cellular biochemistry,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
April 2007, Zhongguo shi yan xue ye xue za zhi,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
December 1993, Experimental cell research,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
November 2000, The American journal of pathology,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
April 2008, The Journal of pharmacy and pharmacology,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
September 1998, The Journal of biological chemistry,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
May 2007, Journal of biochemistry,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
May 1991, Journal of cellular physiology,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
March 2001, Transplantation,
T F Zioncheck, and L Richardson, and J Liu, and L Chang, and K L King, and G L Bennett, and P Fügedi, and S M Chamow, and R H Schwall, and R J Stack
December 2001, The Journal of biological chemistry,
Copied contents to your clipboard!